Clinical Trial Update: Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity

View source ↗

Summary

This clinical trial is evaluating postoperative stereotactic body radiotherapy with adaptive technology to minimize toxicity in prostate cancer patients, and it…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Cancer (CRPC) | Status: RECRUITING